At less than 4 weeks after TB treatment initiation, TB-HIV co-infected individuals exhibited increased concentrations of several plasma factors of innate immune origin, such as IL-1β, IL-6, IL-8 and CCL2. This evidence concerns the gene IL6 and tuberculosis.